Parkside Financial Bank & Trust’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-280
Closed -$3K – 1696
2020
Q3
$3K Hold
280
– – ﹤0.01% 1109
2020
Q2
$4K Hold
280
– – ﹤0.01% 1014
2020
Q1
$2K Hold
280
– – ﹤0.01% 1189
2019
Q4
$6K Hold
280
– – ﹤0.01% 926
2019
Q3
$4K Hold
280
– – ﹤0.01% 1022
2019
Q2
$3K Hold
280
– – ﹤0.01% 1121
2019
Q1
$3K Buy
280
+140
+100% +$1.87K ﹤0.01% 1115
2018
Q4
$2K Buy
+140
New +$2.19K ﹤0.01% 1122
2018
Q3
– Sell
-163
Closed -$4K – 1654
2018
Q2
$4K Buy
+163
New +$4.23K ﹤0.01% 953

Other funds holding FLXN

Parkside Financial Bank & Trust's FLXN Position: Q4 2020 in Review

Parkside Financial Bank & Trust sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2020, closing a stake of 280 shares — an estimated $3K sold.

Parkside Financial Bank & Trust first reported a position in FLXN in Q2 2018 and held it in 9 quarters. The position peaked at $6K in Q4 2019. 141 funds tracked by Wall St. Rank hold FLXN as of Q4 2020.

  • Parkside Financial Bank & Trust reported no remaining Flexion Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 280 Flexion Therapeutics, Inc. shares in Q4 2020, an estimated $3K.
  • Parkside Financial Bank & Trust first reported a position in Flexion Therapeutics, Inc. in Q2 2018 and held it in 9 quarters.
  • Parkside Financial Bank & Trust's Flexion Therapeutics, Inc. position peaked at $6K in Q4 2019.
  • 141 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2020.

Based on Parkside Financial Bank & Trust's 13F filing for Q4 2020, filed 9 Feb 2021.